STEVEN BARNETT: Open Payments
NPI 1134175557 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,533 in 18 payments from 5 companies in 2025. Trend: 2023 $237 · 2024 $410 · 2025 $3,533
Consulting: $2,780Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $3,057 |
| ViiV Healthcare Company | 10 | $420 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Napo Pharmaceuticals Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: APRETUDE, CABENUVA, DOVATO, PIFELTRO, RUKOBIA, Mytesi, CAPLYTA.
Industry payments across SC — which companies pay providers there.
